EXPERIMENTAL RESEARCH OF EFFECT COMBINED WITH NEW RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR AND ETOPOSIDE IN MURINE PNEUMOCELLULAR CARCINOMA / 肿瘤研究与临床
Cancer Research and Clinic
;
(6)1999.
Artigo
em Chinês
| WPRIM
| ID: wpr-674691
ABSTRACT
Objective To investigate the inhibitive effects of treatment with new recombinant humantumor necrosis factor (nrhTNF) and/or etoposide (VP16) on murine lung cancer. Methods Tumor-bearingmice were randomly divided into four groups. NS, nrhTNF, VP16, nrhTNF and VP16, were respectivelyinjected into endoneoplasm in every group. Results Inhibition rate in nrhTNF group and VP16 group were33.71 % and 30. 46% respectively and resulted in tumor necrosis to a certain degree. The number of lungmetastatic tumors in the mentioned groups above were less than that in control group (P
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Cancer Research and Clinic
Ano de publicação:
1999
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS